USA TODAY |
Biotech firm StemCells to cease operations
USA TODAY Biotech firm StemCells Inc. plans to dissolve its operations following the failure of a clinical trial that was testing a treatment for spinal cord injury. The Newark, Calif.-based firm said it would assess options to "monetize its intellectual ... StemCells, Inc. Announces Termination of Phase II Pathway Study Following Review of Data Why StemCells Inc (STEM) Stock Is Cratering Today StemCells nixes mid-stage study in spinal cord injury; shares plummet 82% |
from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNHUQxbH3rAljpbwSmuEgqT--VWuOg&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779123919352&ei=jrpNV9m4KcOP3gHI_KmQAw&url=http://www.usatoday.com/story/money/2016/05/31/stemcells-liquidation-spinal-cord-injury-treatment/85184086/
via IFTTT
No comments:
Post a Comment